EBMT ABSTRACTS SUBMITTED TO ASH 2014
1. Similar Outcome of Upfront Unrelated and Matched Sibling Donor Hematopoietic
Stem Cell Transplantation in Idiopathic Aplastic Anaemia of Childhood and
Adolescence: A Cohort Controlled Study on Behalf of the UK Paediatric BMT WP, of the
PD WP and of the SAA WP of the EBMT
Result Type: Paper
Number: 256
Presenter: Carlo Dufour
Program: Oral and Poster Abstracts
Session: 508. Bone Marrow Failure: Molecular Mechanisms: Diagnosis and Treatment
Time and Location:
Monday, December 8, 2014: 7:00 AM-8:30 AM
West Building, 3005-3007 (Moscone Center)
2. Allogeneic Hematopoietic Stem-Cell Transplantation (HSCT) in First Complete
Remission Is Superior Compared to Chemotherapy/Autologous HSCT in Patients with
Intermediate-Risk Cytogenetics Acute Myeloid Leukemia Lacking Mutations
in NPM1, FLT3-ITD, and CEBPA: A Joint Study of AMLSG, Cetlam and Acute Leukemia
Working Party of EBMT
Result Type: Paper
Number: 324
Presenter: Jordi Esteve
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Comparative Transplantation
Outcomes
Time and Location:
Monday, December 8, 2014: 7:00 AM-8:30 AM
South Building, Esplanade 304-306-308 (Moscone Center)
3. Long-Term Follow-up Data Support the Curative Potential of Allogeneic Hematopoietic
Cell Transplantation in Patients with Chronic Lymphocytic Leukemia: A Retrospective
Analysis from the Chronic Malignancies Working Party of the EBMT
Result Type: Paper
Number: 2561
Presenter: Michel Van Gelder
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 7, 2014: 6:00 PM-8:00 PM
North Building, Hall E (Moscone Center)
1
4. Reduced Intensity Vs. Standard Conditioning Followed By Allogeneic Stem Cell
Transplantation for Patients with MDS or Secondary AML: A Prospective, Randomized
Phase III Study of the Chronic Malignancies Working Party of the EBMT (RICMAC-Trial)
Result Type: Paper
Number: 320
Presenter: Nicolaus Kröger
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Comparative Transplantation
Outcomes
Time and Location:
Monday, December 8, 2014: 7:00 AM-8:30 AM
South Building, Esplanade 304-306-308 (Moscone Center)
5. Haplotransplants Versus Other Alternative Donors for Allogeneic Stem Cell
Transplantation in Non Hodgkin Lymphoma (NHL): A Retrospective Analysis of the
EBMT Lymphoma Working Party
Result Type: Paper
Number: 2573
Presenter: Sascha Dietrich
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 7, 2014: 6:00 PM-8:00 PM
North Building, Hall E (Moscone Center)
6. Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndrome
(MDS) Patients at Lower Risk According to International Prognostic Scoring System
(IPSS) : A Retrospective Study on Behalf of the Cmwp of the EBMT
Result Type: Paper
Number: 2530
Presenter: Marie Robin
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 7, 2014: 6:00 PM-8:00 PM
North Building, Hall E (Moscone Center)
7. Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Evolution
and Outcomes over More Than Two Decades within EBMT Centers
Result Type: Paper
Number: 2554
Presenter: Mauricette Michallet
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 7, 2014: 6:00 PM-8:00 PM
North Building, Hall E (Moscone Center)
2
8. Influence of Preexisting Invasive Aspergillosis on Allo-HSCT Outcome: A Retrospective
EBMT Analysis from the Infectious Diseases and Acute Leukemia Working Parties
Result Type: Paper
Number: 185
Presenter: Olaf Penack
Program: Oral and Poster Abstracts
Session: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and
Acute Transplant Toxicities: Infections in Transplant Recipients
Time and Location:
Sunday, December 7, 2014: 4:30 PM-6:00 PM
West Building, 2009-2011-2022-2024 (Moscone Center)
9. Allogeneic Hematopoietic Cell Transplantation in AML with Normal Karyotype and
NPM1 Mutated FLT3-ITD Negative: A Retrospective Analysis from the Acute Leukemia
Working Party of EBMT
Result Type: Paper
Number: 1230
Presenter: Ali Bazarbachi
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster I
Time and Location:
Saturday, December 6, 2014: 5:30 PM-7:30 PM
North Building, Hall E (Moscone Center)
10. Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome; A More Favorable
Outcome after Fludarabine and Treosulfan Conditioning. a Survey on Behalf of the
Chronic Malignancies Working Party of the EBMT
Result Type: Paper
Number: 1216
Presenter: Avichai Shimoni
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster I
Time and Location:
Saturday, December 6, 2014: 5:30 PM-7:30 PM
North Building, Hall E (Moscone Center)
11. Impact of CD3+ and CD34+ Doses in the Mobilized Peripheral Blood Stem Cell Grafts on
the Outcome of Reduced-Intensity Conditioning Allogenic Transplantation from
Matched Unrelated Donors for Acute Myeloid Leukemia – an Analysis from the Acute
Leukemia Working Party of the EBMT
Result Type: Paper
Number: 190
Presenter: Tomasz Czerw
Program: Oral and Poster Abstracts
Session: 722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune
Reconstitution: Risk Factors for GVHD and Outcomes
Time and Location:
Sunday, December 7, 2014: 4:30 PM-6:00 PM
West Building, 3009-3011-3022-3024 (Moscone Center)
3
12. Allogeneic HCT in Patients with 17p-CLL: Results of a Non-Interventional Study of the
EBMT & Eric
Result Type: Paper
Number: 1224
Presenter: Johannes Schetelig
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster I
Time and Location:
Saturday, December 6, 2014: 5:30 PM-7:30 PM
North Building, Hall E (Moscone Center)
13. Does Ex Vivo CD34+ Cell Selection Change the Outcome of Systemic Sclerosis Patients
Treated with Autologous Hematopoietic Stem Cell Transplantation (AHSCT), an Adwp
EBMT Study?
Result Type: Paper
Number: 2517
Presenter: Maria Oliveira
Program: Oral and Poster Abstracts
Session: 731. Clinical Autologous Transplantation: Results: Poster II
Time and Location:
Sunday, December 7, 2014: 6:00 PM-8:00 PM
North Building, Hall E (Moscone Center)
14. Contrasting Factors Determine the Kinetics of Disease Relapse after Allogeneic Stem
Cell Transplantation (allo-SCT) for Acute Myeloid Leukaemia (AML): a Survey from the
Acute Leukaemia Working Party of the EBMT
Result Type: Paper
Number: 3945
Presenter: Charles Craddock
Program: Oral and Poster Abstracts
Session: 723. Clinical Allogeneic and Autologous Transplantation: Late Complications and
Approaches to Disease Recurrence: Poster III
Time and Location:
Monday, December 8, 2014: 6:00 PM-8:00 PM
North Building, Hall E (Moscone Center)
15. Allogeneic HCT with Reduced Intensity Conditioning Versus Autologous HCT for >55
Years Old Patients with Acute Lymphoblastic Leukemia in First Complete Remission: An
Analysis from Acute Leukemia Working Party of the EBMT
Result Type: Paper
Number: 3974
Presenter: Sebastian Giebel
Program: Oral and Poster Abstracts
Session: 731. Clinical Autologous Transplantation: Results: Poster III
Time and Location:
Monday, December 8, 2014: 6:00 PM-8:00 PM
North Building, Hall E (Moscone Center)
4
16. Autologous Stem Cell Transplantation (ASCT) for the Treatment of Patients with
Waldenstrom’s Macroglobulinemia / Lymphoplasmacytic Lymphoma (WM/LPL). a Risk
Factor Analysis By the European Society for Blood and Marrow Transplantation (EBMT)
Lymphoma Working Party
Result Type: Paper
Number: 678
Presenter: Charalampia Kyriakou
Program: Oral and Poster Abstracts
Session: 731. Clinical Autologous Transplantation: Results: Clinical Results in Lymphoid
Malignancies
Time and Location:
Monday, December 8, 2014: 4:30 PM-6:00 PM
West Building, 3001-3003-3014-3016 (Moscone Center)
17. Activity and Tolerability of Azacitidine in Patients Who Relapse after Allogeneic Stem
Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) and Myelodysplasia
(MDS): a Survey from the European Society for Blood and Marrow Transplantation
(EBMT
Result Type: Paper
Number: 2506
Presenter: Charles Craddock
Program: Oral and Poster Abstracts
Session: 723. Clinical Allogeneic and Autologous Transplantation: Late Complications and
Approaches to Disease Recurrence: Poster II
Time and Location:
Sunday, December 7, 2014: 6:00 PM-8:00 PM
North Building, Hall E (Moscone Center)
18. Higher Doses of Antithymocyte Globulin (ATG) Increase the Risk of Relapse in Acute
Myeloid Leukemia (AML) Patients Undergoing Matched Related Donor Allogeneic
Transplantation in First Complete Remission (CR1): An Analysis from the Acute
Leukemia Working Party of EBMT
Result Type: Paper
Number: 729
Presenter: Raynier Devillier
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Improving Transplantation Outcomes
Time and Location:
Monday, December 8, 2014: 6:15 PM-7:45 PM
South Building, Esplanade 304-306-308 (Moscone Center)
19. Matched and Mismatched Unrelated Donor Versus Unmanipulated Haploidentical
Donors for Hematopoietic Cell Transplantation in Acute Leukemia in Remission: A Pair
Matched Analysis on Behalf of the Acute Leukemia Working Party (ALWP) of the
European Society for Blood and Marrow Transplantation (EBMT)
Result Type: Paper
Number: 1219
Presenter: Simona Piemontese
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster I
5
Time and Location:
Saturday, December 6, 2014: 5:30 PM-7:30 PM
North Building, Hall E (Moscone Center)
20. Autologous Stem Cell Transplantation for Primary Mediastinal B Cell Lymphoma in the
Rituximab Era: A Retrospective Study By the EBMT Lymphoma Working Party
Result Type: Paper
Number: 1195
Presenter: Irit Avivi
Program: Oral and Poster Abstracts
Session: 731. Clinical Autologous Transplantation: Results: Poster I
Time and Location:
Saturday, December 6, 2014: 5:30 PM-7:30 PM
North Building, Hall E (Moscone Center)
21. Prediction of Allogeneic HSCT Related Mortality in Acute Leukemia: Exploring
Boundaries of Prediction through Machine Learning Based Modeling. a Data Mining
Study from the Acute Leukemia Working Party (ALWP) of the EBMT
Result Type: Paper
Number: 2568
Presenter: Roni Shouval
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 7, 2014: 6:00 PM-8:00 PM
North Building, Hall E (Moscone Center)
22. RIC Allo-SCT with Flu/Bu in Comparison to Flu/Mel for AML Results in Similar Overall
Survival: A Report from the ALWP of the EBMT
Result Type: Paper
Number: 545
Presenter: Frederic Baron
Program: Oral and Poster Abstracts
Session: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and
Acute Transplant Toxicities: Novel Conditioning Regimens
Time and Location:
Monday, December 8, 2014: 2:45 PM-4:15 PM
West Building, 2006-2008 (Moscone Center)
23. Haploidentical Versus Autologous Stem Cell Transplantation in Adult Acute Leukemia:
A Matched Pair Analysis from the Acute Leukemia Working Party of the European
Society for Blood and Marrow Transplantation (EBMT)
Result Type: Paper
Number: 2508
Presenter: Norbert Gorin
Program: Oral and Poster Abstracts
Session: 723. Clinical Allogeneic and Autologous Transplantation: Late Complications and
Approaches to Disease Recurrence: Poster II
Time and Location:
Sunday, December 7, 2014: 6:00 PM-8:00 PM
6
North Building, Hall E (Moscone Center)
24. Double Cord Blood Transplantation: Incidence, Organ Involvement and Risk Factors of
Acute Graft Versus Host Disease. a Retrospective Analysis on Behalf of Eurocord, ALWP
and Cqwp-EBMT
Result Type: Paper
Number: 187
Presenter: Erick Xavier
Program: Oral and Poster Abstracts
Session: 722. Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune
Reconstitution: Risk Factors for GVHD and Outcomes
Time and Location:
Sunday, December 7, 2014: 4:30 PM-6:00 PM
West Building, 3009-3011-3022-3024 (Moscone Center)
25. High Dose Therapy and Autologous Stem Cell Transplantation in Marginal Zone
Lymphoma : An EBMT-FIL-Gimeto Retrospective Study
Result Type: Paper
Number: 2526
Presenter: Irit Avivi
Program: Oral and Poster Abstracts
Session: 731. Clinical Autologous Transplantation: Results: Poster II
Time and Location:
Sunday, December 7, 2014: 6:00 PM-8:00 PM
North Building, Hall E (Moscone Center)
26. Outcomes of Cord Blood Transplantation Using Reduced Intensity Conditioning for
Chronic Lymphocytic Leukemia: A Retrospective Study on Behalf of Eurocord, SFGM-TC
and Cqwp-EBMT
Result Type: Paper
Number: 2581
Presenter: Erick Xavier
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 7, 2014: 6:00 PM-8:00 PM
North Building, Hall E (Moscone Center)
27. Outcomes after Double Umbilical Cord Blood Transplantation in Children: A Survey on
Behalf of Eurocord and PDWP-EBMT
Result Type: Paper
Number: 2570
Presenter: Federica Giannotti
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 7, 2014: 6:00 PM-8:00 PM
North Building, Hall E (Moscone Center)
7
28. Unrelated Cord Blood Versus Non-T Cell Depleted Haploidentical Stem Cell
Transplantation: Comparable Results in Adults with Acute Leukemia, a Eurocord and
ALWP-EBMT Study
Result Type: Paper
Number: 1227
Presenter: Annalisa Ruggeri
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster I
Time and Location:
Saturday, December 6, 2014: 5:30 PM-7:30 PM
North Building, Hall E (Moscone Center)
29. Comparison Between Related T-Cell Depleted HLA-Haploidentical Stem Cell
Transplantation (TCD-Haplo) and Umbilical Cord Blood Transplantation (UCBT) in
Pediatric Patients with Acute Leukemia, a Eurocord, PDWP-EBMT Study
Result Type: Paper
Number: 1215
Presenter: Franco Locatelli
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster I
Time and Location:
Saturday, December 6, 2014: 5:30 PM-7:30 PM
North Building, Hall E (Moscone Center)
30. The Hierarchy of Alternative Donors for Allogeneic Hematopoietic Stem Cell
Transplantation in Poor Risk AML in CR1: 10/10 Matched Unrelated Donors Still to be
Preferred over Haplo-Identical Donors or Umbilical Cord Blood
Result Type: Paper
Number: 681
Presenter: Jurjen Versluis
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Haploidentical and Beyond
Time and Location:
Monday, December 8, 2014: 4:30 PM-6:00 PM
West Building, 3005-3007 (Moscone Center)
31. Myeloablative Versus Reduced Intensity Allogeneic Stem Cell Transplantation
in Relapsed Hodgkin’s Lymphoma in Recent Years. a Retrospective Analysis of the
Lymphoma Working Party of the European Group for Blood and Marrow
Transplantation
Result Type: Paper
Number: 2562
Presenter: Sonja Genadieva Stavrik
Program: Oral and Poster Abstracts
Session: 732. Clinical Allogeneic Transplantation: Results: Poster II
Time and Location:
Sunday, December 7, 2014: 6:00 PM-8:00 PM
North Building, Hall E (Moscone Center)
8
32. Genetic Determinants of Busulfan Clearance and Outcomes in Pediatric Patients
Undergoing Hematopoietic Stem Cell Transplantation- Result of a Multicentric
Prospective Study on Behalf of the Pediatric Disease Working Party of the European
Blood and Marrow Transplantation Group
Result Type: Paper
Number: 424
Presenter: Marc Ansari
Program: Oral and Poster Abstracts
Session: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and
Acute Transplant Toxicities: Personalizing Transplant Outcomes
Time and Location:
Monday, December 8, 2014: 10:30 AM-12:00 PM
West Building, 3001-3003-3014-3016 (Moscone Center)
33. Safety and Efficacy of Thiotepa-Based Conditioning Therapy for Allogeneic
Transplantation in Acute Myeloid Leukemia - a Survey from the Acute Leukemia
Working Party of the European Group for Blood and Marrow Transplantation
Result Type: Paper
Number: 3895
Presenter: Sandra Eder
Program: Oral and Poster Abstracts
Session: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment and
Acute Transplant Toxicities: Poster III
Time and Location:
Monday, December 8, 2014: 6:00 PM-8:00 PM
North Building, Hall E (Moscone Center)
9